Wearable remote monitoring for pediatric heart failure patients
Official title: There's No Place Like Home…Feasibility of Remote Physiological Monitoring in Childhood Heart Failure
Run by University of Alberta · NCT06969560 · Data updated 2026-11-12
This study is testing a new wearable device that helps track the health of kids with heart failure to see if it can improve their care at home and reduce hospital visits.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 8 Years to 18 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Alberta Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 4 sites (Edmonton, Alberta and 3 other locations) |
| Status | Recruiting |
| Started | February 24, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2028 |
| Registry record updated | May 11, 2026 |
| Trial ID | NCT06969560 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are pediatric outpatients aged 8-18 with or at risk of deteriorating heart failure.
✕Probably not a fit
Patients who are not outpatients or do not meet the specified age and health criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on the use of wearable remote physiologic monitoring (RPM) technology to track the health of pediatric patients with heart failure or those at risk of developing it. By enrolling 100 outpatients aged 8-18 from four tertiary pediatric heart failure centers in Canada, the study aims to utilize a Bluetooth-enabled textile device to monitor vital signs such as heart rate, respiratory rate, and blood pressure. The goal is to improve home-based care and reduce reliance on hospital visits, particularly for vulnerable populations. The study will also explore the integration of machine learning algorithms to predict health deterioration based on collected data.
Why it matters
Potential benefit: If successful, this approach could provide safer, more equitable home-based care for children with heart failure.
How similar studies have gone: While RPM has been successful in adult populations, this approach is novel and untested in pediatric heart failure care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients from 8-18 years of age who are outpatients at time of study enrollment. * Patients with a chest size of at least 69.85 cm in perimeter/circumference (as measured under the pectoral muscles) * Patients at-risk for heart failure and with American Heart Association (AHA) Stage B-D Heart Failure will be included in this study irrespective of heart failure medication use. * HF etiologies include: congenital cardiac malformation with systemic ventricular systolic dysfunction, idiopathic cardiomyopathy, familial/inherited and/or genetic cardiomyopathy, history of myocarditis with persistent ventricular dysfunction, neuromuscular disorder, inborn error of metabolism, mitochondrial disorder, acquired (chemotherapy, iatrogenic, infection, rheumatic, or nutritional), ischemic (e.g., Kawasaki disease and post-operative HF), and left ventricular non-compaction, restrictive cardiomyopathy and HCM with systolic or diastolic dysfunction. Exclusion Criteria: * Patients within 3 months of a surgery. * Patients supported by ventricular assist device at study onset. * Inability to use technology due to physical or cognitive impairment in the patient or caregiver. * Non-English speaking. * Patients who have an implantable cardiac defibrillator or pacemaker * Patients whose chest size is too large or small to fit available sizes of the Skiin device.
Where it's running
-
Stollery Children's Hospital
Edmonton, Alberta, Canada Recruiting -
BC Children's Hospital
Vancouver, British Columbia, Canada Not yet recruiting -
The Hospital for Sick Children
Toronto, Ontario, Canada Not yet recruiting -
CHU Sainte-Justine
Montreal, Quebec, Canada Not yet recruiting
Study contacts
- Principal investigator: Jennifer L Conway, MD, MSc — University of Alberta/Stollery Children's Hospital
- Study coordinator: Jennifer L Conway, MD, MSc
- Email: jennifer.conway2@ahs.ca
- Phone: 780-407-4848
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.